| __timestamp | Alpine Immune Sciences, Inc. | ImmunityBio, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 1595000 |
| Thursday, January 1, 2015 | 16054000 | 11434000 |
| Friday, January 1, 2016 | 23316000 | 26546000 |
| Sunday, January 1, 2017 | 10626000 | 39778000 |
| Monday, January 1, 2018 | 28970000 | 53418000 |
| Tuesday, January 1, 2019 | 35847000 | 111997000 |
| Wednesday, January 1, 2020 | 27185000 | 139507000 |
| Friday, January 1, 2021 | 58742000 | 195958000 |
| Saturday, January 1, 2022 | 70243000 | 248149000 |
| Sunday, January 1, 2023 | 80904000 | 232366000 |
Infusing magic into the data realm
In the ever-evolving world of biotechnology, research and development (R&D) investments are the lifeblood of innovation. Over the past decade, Alpine Immune Sciences, Inc. and ImmunityBio, Inc. have been at the forefront of this transformative journey.
Since 2014, Alpine Immune Sciences has steadily increased its R&D spending, culminating in a remarkable 560% growth by 2023. This commitment underscores their dedication to pioneering new therapies and advancing scientific discovery.
ImmunityBio, Inc. has demonstrated an even more aggressive investment strategy, with R&D expenses skyrocketing by over 14,500% from 2014 to 2023. This surge reflects their relentless pursuit of breakthroughs in immunotherapy and cancer treatment.
Both companies exemplify the biotech sector's unwavering commitment to innovation, with ImmunityBio leading the charge in recent years. As we look to the future, these investments promise to reshape the landscape of healthcare and medicine.
Zoetis Inc. or Alpine Immune Sciences, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Alpine Immune Sciences, Inc.
Who Prioritizes Innovation? R&D Spending Compared for GSK plc and Alpine Immune Sciences, Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and ImmunityBio, Inc.
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs ImmunityBio, Inc.
R&D Insights: How Corcept Therapeutics Incorporated and ImmunityBio, Inc. Allocate Funds
Research and Development Investment: Axsome Therapeutics, Inc. vs Alpine Immune Sciences, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs CymaBay Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc.
ImmunityBio, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for ImmunityBio, Inc. and Mesoblast Limited